Literature DB >> 22213840

Heavy manual work, exposure to vibration and Dupuytren's disease? Results of a surveillance program for musculoskeletal disorders.

Alexis Descatha1, Julie Bodin, Catherine Ha, Pierre Goubault, Marine Lebreton, Jean François Chastang, Ellen Imbernon, Annette Leclerc, Marcel Goldberg, Yves Roquelaure.   

Abstract

INTRODUCTION: This study aimed to determine the prevalence of Dupuytren's disease in men and its relationship with work exposure, particularly heavy manual work with and without significant use of vibrating tools, using data from a surveillance program for musculoskeletal disorders.
METHOD: This cross-sectional study was conducted in France between 2002 and 2005. Dupuytren's disease was diagnosed clinically by one of 83 occupational physicians. Exposure in relation to work status and occupational risk factors was assessed with a self-administered questionnaire, and categorised according to vibration exposure (defined as use of vibrating tools for ≥2 h/day), heavy manual work without vibration exposure (defined as use of hand tools for ≥2 h/day (use of vibrating tools for ≥2 h/day excluded) and Borg scale ≥15/20) and no such exposure. Bivariate and multivariate associations using logistic models were recorded in men and in those with >10 years in the same job.
RESULTS: Of 2161 men, 1.3% (n=27) had Dupuytren's disease (mean age 47.1±6.7 years). Heavy manual work without vibration exposure was significantly associated with the condition (adjusted OR (aOR) 3.9; 95% CI 1.3 to 11.5) adjusted on age and diabetes), as was use of vibrating tools (aOR 5.1; 2.1 to 12.2). These associations remained significant among subjects with >10 years in the same job, with increases in aOR of 6.1 (1.5 to 25.0) and 10.7 (3.4 to 34.6), respectively.
CONCLUSION: Despite the limited number of cases, occupational exposure, including both vibration exposure and heavy manual work without significant vibration exposure, was associated with Dupuytren's disease.

Entities:  

Mesh:

Year:  2012        PMID: 22213840      PMCID: PMC3815440          DOI: 10.1136/oemed-2011-100319

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  18 in total

1.  Criteria document for evaluating the work-relatedness of upper-extremity musculoskeletal disorders.

Authors:  J K Sluiter; K M Rest; M H Frings-Dresen
Journal:  Scand J Work Environ Health       Date:  2001       Impact factor: 5.024

2.  The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales.

Authors:  A A Khan; O J Rider; C U Jayadev; C Heras-Palou; H Giele; M Goldacre
Journal:  J Hand Surg Br       Date:  2004-02

Review 3.  Clinical associations of Dupuytren's disease.

Authors:  M G Hart; G Hooper
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

4.  Dupuytren's disease: personal factors and occupational exposure.

Authors:  Gérard Lucas; Anne Brichet; Yves Roquelaure; Annette Leclerc; Alexis Descatha
Journal:  Am J Ind Med       Date:  2008-01       Impact factor: 2.214

Review 5.  Can Dupuytren's contracture be work-related?: review of the evidence.

Authors:  G M Liss; S R Stock
Journal:  Am J Ind Med       Date:  1996-05       Impact factor: 2.214

6.  Epidemiologic surveillance of upper-extremity musculoskeletal disorders in the working population.

Authors:  Yves Roquelaure; Catherine Ha; Annette Leclerc; Annie Touranchet; Marine Sauteron; Maria Melchior; Ellen Imbernon; Marcel Goldberg
Journal:  Arthritis Rheum       Date:  2006-10-15

7.  [Occupational exposure to vibration and Dupuytren's disease: a case-controlled study].

Authors:  P L Cocco; P Frau; M Rapallo; D Casula
Journal:  Med Lav       Date:  1987 Sep-Oct       Impact factor: 1.275

8.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

9.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

Review 10.  Should we consider Dupuytren's contracture as work-related? A review and meta-analysis of an old debate.

Authors:  Alexis Descatha; Pénélope Jauffret; Jean-François Chastang; Yves Roquelaure; Annette Leclerc
Journal:  BMC Musculoskelet Disord       Date:  2011-05-16       Impact factor: 2.362

View more
  6 in total

1.  Dupuytren's Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study.

Authors:  Ilaria Morelli; Gianfranco Fraschini; Arianna E Banfi
Journal:  Arch Bone Jt Surg       Date:  2017-11

2.  Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years.

Authors:  Mattias Rydberg; Malin Zimmerman; Jin Persson Löfgren; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

3.  Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants.

Authors:  Sophie A Riesmeijer; Paul M N Werker; Ilja M Nolte
Journal:  Eur J Hum Genet       Date:  2019-07-30       Impact factor: 4.246

Review 4.  Rheumatic effects of vibration at work.

Authors:  Keith T Palmer; Massimo Bovenzi
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-30       Impact factor: 4.098

5.  Dupuytren's contracture and occupational exposure to hand-transmitted vibration.

Authors:  Keith T Palmer; Stefania D'Angelo; Holly Syddall; Michael J Griffin; Cyrus Cooper; David Coggon
Journal:  Occup Environ Med       Date:  2014-01-21       Impact factor: 4.402

6.  The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Mohammadbagher Heydari; Masoud Hassanabadi; Mohsen Kazeminia; Nikzad Farshchian; Mehrdad Niaparast; Yousef Solaymaninasab; Masoud Mohammadi; Shamarina Shohaimi; Alireza Daneshkhah
Journal:  J Orthop Surg Res       Date:  2020-10-28       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.